Related Experiment Video
Updated: Sep 27, 2025

08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy
Juan Yue1,2, Qian Mei3,4, Panyong Wang1,2
1School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.
Journal of Nanobiotechnology
|April 8, 2022
Summary
This study introduces novel nanoparticles for photo-immunotherapy, combining photodynamic and photothermal therapy with checkpoint blockade to effectively treat tumors and prevent metastasis with minimal toxicity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Cancer immunotherapy faces challenges from tumor immune escape and adverse effects.
- Photo-immunotherapy, combining phototherapy (PDT/PTT) with immunotherapy, enhances treatment efficacy.
- Novel nanoparticle systems are needed to improve drug delivery and therapeutic synergy.
Purpose of the Study:
- To develop and evaluate mesoporous hexagonal core-shell zinc porphyrin-silica nanoparticles (MPSNs) for advanced photo-immunotherapy.
- To assess MPSNs as a drug carrier and photosensitizer for synergistic cancer treatment.
- To investigate the efficacy of MPSNs-based photo-immunotherapy combined with checkpoint blockade against primary and metastatic tumors.
Main Methods:
- Synthesis and characterization of MPSNs with zinc porphyrin core and mesoporous silica shell.
- Loading MPSNs with R837 (imiquimod) for pH-responsive drug release and combining with programmed death ligand-1 (PD-L1) checkpoint blockade.
- Evaluating laser-triggered photodynamic therapy (PDT) and photothermal therapy (PTT) activity of MPSNs@R837.
- Assessing the induction of immunogenic cell death, dendritic cell maturation, and tumor-specific immune responses in vivo.
- Investigating the therapeutic effects on primary and metastatic tumors and systemic toxicity.
Main Results:
- MPSNs demonstrated high laser-triggered PDT and PTT activity and excellent drug loading capacity.
- MPSNs@R837 induced efficient immunogenic cell death and promoted dendritic cell maturation via pH-responsive R837 release.
- The combined therapy of MPSNs@R837, PDT, PTT, and PD-L1 blockade significantly inhibited primary and metastatic tumors.
- The treatment exhibited negligible systemic toxicity.
Conclusions:
- MPSNs serve as effective photosensitizers and drug carriers for synergistic photo-immunotherapy.
- The developed therapeutic strategy integrating PTT, PDT, and checkpoint blockade shows significant potential for suppressing cancer metastasis.
- This approach offers a promising avenue for more effective and safer cancer treatment.
Keywords:
Dendritic cellHexahedron zinc porphyrin mesoporous nanoparticlesImmune responsePD-L1 checkpoint blockadePhoto-immunotherapy
